Gryphon-Backed Metagenics Acquires UK Probiotic Brand Symprove

Maven Invests Growth Capital in Covestus; Covestus Acquires Probio7

July 19, 2024

Consumer Products

Maven Investor Partners, via Maven and SWIF Maven Equity Finance (part of the South West Investment Fund), has made a growth capital investment in Cheltenham-based Covestus to support its buy-and-build strategy. The funding will help Covestus scale its portfolio of consumer healthcare brands and has enabled the acquisition of probiotic supplement brand Probio7.

Ginkgo Bioworks Acquires Proof Diagnostics

February 28, 2024

Biotechnology

Ginkgo Bioworks has acquired Proof Diagnostics to integrate Proof's OMEGA nuclease libraries and portable diagnostic technologies into Ginkgo’s gene therapy and genetic medicines platform. The deal expands Ginkgo’s gene editing toolkit and diagnostic capabilities to better serve customers developing programmable medicines and rapid detection systems.

Kadenwood Acquires Probulin Probiotic Brand from HempFusion Wellness

January 18, 2023

Food & Beverage

Kadenwood, a Newport Beach-based plant‑based wellness company, has acquired Probulin, a probiotic and microbiome health brand previously owned by HempFusion Wellness, Inc. The deal expands Kadenwood’s portfolio into the probiotics category and adds retail and e‑commerce distribution channels to accelerate growth across natural, drug and mass retail outlets.

Sumeru Equity Partners Invests $70M Growth Round in iProov

January 6, 2022

Cybersecurity

Sumeru Equity Partners committed $70 million in growth capital to iProov to accelerate the biometric face-authentication provider’s expansion in the United States and internationally. The investment will support product and partner-network growth, hiring, and scaling of iProov’s Genuine Presence and Liveness Assurance technologies.

Gryphon Investors Acquires Metagenics from Alticor

December 1, 2021

Consumer Products

Gryphon Investors signed a definitive agreement to acquire Metagenics, Inc. from Alticor, with the transaction expected to close in Q4 2021. WhiteHorse Capital provided a first-lien credit facility to Meta Buyer, LLC to support the acquisition; Gryphon will partner with Metagenics' management to invest in global growth, including potential strategic acquisitions.

PanTheryx Acquires TruBiotics Brand from Bayer HealthCare LLC

March 1, 2021

Food & Beverage

PanTheryx, a Phoenix-based nutrition and biotechnology company, acquired the TruBiotics probiotic supplement brand and related trademarks from Bayer HealthCare LLC. The acquisition adds a recognized probiotics brand to PanTheryx’s portfolio to expand its digestive and immune health product lines and to accelerate growth through existing retail and e‑commerce channels.